| Pharmaceutical Information |
| Drug Name |
Esmolol |
| Drug ID |
BADD_D00813 |
| Description |
Esmolol, commonly marketed under the trade name Brevibloc, is a cardioselective beta-1 receptor blocker. It has a rapid onset but short duration of action without causing significant intrinsic sympathomimetic or membrane stabilizing activities at recommended therapeutic doses. It works by blocking beta-adrenergic receptors in the heart, which leads to decreased force and rate of heart contractions. Esmolol prevents the action of two naturally occurring substances: epinephrine and norepinephrine. |
| Indications and Usage |
For the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other emergent circumstances where short term control of ventricular rate with a short-acting agent is desirable. Also used in noncompensatory sinus tachycardia where the rapid heart rate requires specific intervention. |
| Marketing Status |
approved |
| ATC Code |
C07AB09 |
| DrugBank ID |
DB00187
|
| KEGG ID |
D07916
|
| MeSH ID |
C036604
|
| PubChem ID |
59768
|
| TTD Drug ID |
D03XTC
|
| NDC Product Code |
Not Available |
| UNII |
MDY902UXSR
|
| Synonyms |
esmolol | Brevibloc | esmolol hydrochloride | ASL 8052 | ASL-8052 |
|
| Chemical Information |
| Molecular Formula |
C16H25NO4 |
| CAS Registry Number |
81147-92-4 |
| SMILES |
CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
